We aimed to assess the impact of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the management of patients with suspected large vessel vasculitis.
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis / Fuchs, M., Briel, M., Daikeler, T., Walker, U.A., Rasch, H., Berg, S., Ng, Q.K.T., Raatz, H., Jayne, D., Kötter, I., Blockmans, D., Cid, M.C., Prieto González, S., Lamprecht, P., Salvarani, C., Karageorgaki, Z., Watts, R., Luqmani, R., Müller Brand, J., Tyndall, A., et al.. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7089. - 39:2(2012), pp. 344-353. [10.1007/s00259-011-1967-x]
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis
SALVARANI, CARLO;
2012
Abstract
We aimed to assess the impact of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) on the management of patients with suspected large vessel vasculitis.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
